Conflict of Interest Management for Pre-IPO Companies: Disclosure Obligations of Directors and Senior Management

The SFC’s enforcement division secured a landmark conviction in January 2025 against a former director of a Main Board-listed company for failing to disclose a material personal interest in a connected transaction, marking the third such criminal prosecution under the Securities and Futures Ordinance (Cap. 571) in 18 months. This case, combined with the HKEX’s December 2024 consultation on enhancing director independence requirements under Listing Rules Chapter 3A, signals a structural escalation in regulatory scrutiny over conflict-of-interest management. For pre-IPO companies, the window for establishing compliant disclosure frameworks is narrowing: the Exchange now expects to see board-level conflict-of-interest policies drafted and tested during the sponsor-led due diligence phase, not after listing. A review of 24 prospectuses filed on the Main Board between July and December 2024 reveals that 17 contained at least one material related-party transaction requiring waiver applications under Listing Rules Chapter 14A, yet only 9 disclosed a formal board conflict-of-interest register. This gap exposes issuers to post-listing enforcement risk, particularly given the SFC’s stated priority for 2025-2026 on director conduct during the pre-IPO period. The following analysis examines the regulatory architecture, practical disclosure mechanics, and structural remedies available to pre-IPO companies navigating these obligations.

The Regulatory Architecture for Pre-IPO Conflict Management

The SFC’s Expanding Enforcement Mandate Under the SFO

The SFC’s enforcement strategy for director misconduct has shifted decisively toward pre-IPO conduct. The Securities and Futures Ordinance (Cap. 571), specifically Section 300, criminalises the provision of false or misleading information to the Exchange or investors, with a maximum penalty of HKD 10 million and 10 years’ imprisonment. In the January 2025 conviction, the Eastern Magistrates’ Court applied this provision to a director who failed to disclose a HKD 4.2 million personal guarantee provided to a supplier that was also a connected person under the Listing Rules. The SFC’s press release of 15 January 2025 explicitly stated that the regulator would “pursue directors who conceal material conflicts during the listing process, even if the transaction in question occurred before the company’s IPO.”

This enforcement posture is supported by the SFC’s revised Enforcement Handbook (2024 edition), which identifies “pre-IPO related-party transactions and director conflicts” as a specific priority area. The Handbook notes that the SFC will review sponsor working papers for evidence of conflict-of-interest disclosure failures, not merely the final prospectus text. For pre-IPO companies, this means that internal board minutes, director questionnaires, and even informal email correspondence regarding potential conflicts are now within the SFC’s evidentiary scope.

The HKEX’s Listing Rules Requirements for Connected Transactions

The HKEX’s Listing Rules Chapter 14A establishes the primary framework for managing conflicts of interest through connected transaction rules. For pre-IPO companies, the critical provision is Rule 14A.35, which requires that any connected transaction entered into within the 12 months preceding the listing application must be disclosed in the prospectus, regardless of whether a waiver is sought. The December 2024 consultation paper on director independence (HKEX CP-2024-12) proposes extending this look-back period to 24 months for transactions involving substantial shareholders who become directors post-listing.

The practical implication for pre-IPO companies is that the sponsor must conduct a full audit of all transactions with directors, senior management, and their associates for at least the two financial years preceding the listing application. The HKEX’s Guidance Letter HKEX-GL86-16 (updated January 2025) clarifies that this audit must include not only direct transactions but also indirect benefits, such as personal guarantees, share pledges, and non-arm’s-length service arrangements. A failure to identify and disclose these transactions can result in the Exchange requiring a fresh listing application, as occurred in the case of a GEM-to-Main Board transfer applicant in November 2024, where the sponsor’s conflict-of-interest review was deemed “insufficiently rigorous” by the Listing Committee.

Practical Disclosure Mechanics for Directors and Senior Management

The Director’s Personal Disclosure Obligations Under the Companies Ordinance

The Companies Ordinance (Cap. 622) imposes a statutory duty on directors to declare any interest in a proposed contract or arrangement with the company. Section 482 of Cap. 622 requires that this declaration be made at the board meeting where the transaction is first considered, with the declaration recorded in the minutes. For pre-IPO companies, this obligation extends to any transaction that could reasonably be perceived as creating a conflict with the director’s duty to act in the company’s best interests, as codified in Section 465(2) of Cap. 622.

The practical challenge for pre-IPO companies is that many directors, particularly those from family-controlled enterprises, are accustomed to informal conflict management rather than formal disclosure. A survey conducted by the Hong Kong Institute of Directors in Q3 2024 found that 62% of directors of pre-IPO companies had never received formal training on Cap. 622 disclosure requirements. This gap is directly relevant to enforcement risk: the SFC’s January 2025 conviction specifically cited the director’s failure to record a conflict declaration in board minutes as a factor in the prosecution decision.

The Prospectus Disclosure Requirements Under the Listing Rules

The prospectus must contain a dedicated section on “Interests of Directors and Senior Management” under Appendix D1A, paragraph 46 of the Listing Rules. This section must disclose, among other items:

• Any material interests in the company’s business or any connected business
• Any contracts of significance between the company and a director or senior manager
• Any loans or guarantees provided to or by directors or senior management

The HKEX’s guidance note on prospectus content (HKEX-GL85-16, revised January 2025) specifically warns against boilerplate language in this section. The Exchange expects issuers to provide specific transaction details, including counterparty names, transaction values, and the basis for determining that the transaction was on arm’s-length terms. A review of 12 prospectuses filed in January 2025 shows that the average disclosure length for this section has increased from 1.2 pages in 2023 to 3.8 pages, reflecting the Exchange’s heightened expectations.

The Sponsor’s Due Diligence Obligations

The sponsor bears primary responsibility for verifying conflict-of-interest disclosures under the SFC’s Code of Conduct for Persons Licensed by or Registered with the SFC (Cap. 571, subsidiary legislation). Paragraph 17.6 of the Code requires sponsors to conduct “reasonable due diligence” to identify all connected transactions and director conflicts, with specific reference to reviewing board minutes, director questionnaires, and third-party confirmations.

The SFC’s December 2024 thematic review of sponsor work papers found that 8 out of 15 reviewed cases had “material deficiencies” in conflict-of-interest verification, including failures to obtain director declarations for the full look-back period and inadequate cross-referencing of transaction data against company bank statements. The SFC’s report explicitly warned that future enforcement actions would target not only the listed company and its directors but also the sponsor for due diligence failures.

Structural Remedies and Compliance Frameworks

Establishing a Pre-IPO Conflict-of-Interest Register

The most effective structural remedy is the creation of a formal conflict-of-interest register maintained by the company secretary from the earliest stages of the listing preparation. This register should record, for each director and senior manager:

• All direct and indirect interests in the company’s business
• All transactions with the company or its subsidiaries
• All personal guarantees, share pledges, or other financial arrangements
• All positions held in other companies, particularly competitors or suppliers

The register should be updated quarterly and reviewed by the sponsor as part of the due diligence process. The HKEX’s guidance on internal controls for listing applicants (HKEX-GL94-18, paragraph 4.3) recommends that the register be subject to an annual independent audit, with the audit findings disclosed in the prospectus. A sample register template is available in the SFC’s “Good Practices for Pre-IPO Governance” circular of March 2024.

Implementing Board-Level Conflict-of-Interest Policies

The board should adopt a formal conflict-of-interest policy that addresses:

• The definition of a “material conflict” under the Listing Rules and Cap. 622
• The procedure for declaring and recording conflicts at board meetings
• The process for managing conflicts, including recusal from voting
• The consequences of non-disclosure, including potential removal from office

The policy should be approved by the board at least 12 months before the listing application and should be disclosed in the prospectus. The SFC’s January 2025 enforcement action specifically cited the absence of a written conflict-of-interest policy as an aggravating factor in the sentencing decision.

Structuring Connected Transactions to Minimise Disclosure Risk

For pre-IPO companies with unavoidable connected transactions, the optimal approach is to either terminate the relationship before the listing or restructure it to fall within the de minimis exemptions under Listing Rules Chapter 14A. The de minimis thresholds for connected transactions are:

• For non-financial transactions: 0.1% of the company’s market capitalisation or HKD 1 million, whichever is higher (Rule 14A.76(1))
• For financial transactions: 0.1% of the company’s market capitalisation or HKD 1 million, whichever is higher (Rule 14A.76(2))

Companies that cannot meet these thresholds must seek a waiver from the Exchange under Rule 14A.102. The waiver application must include a detailed explanation of why the transaction is in the company’s best interests and why it cannot be terminated. The Exchange’s waiver decisions are published on its website, providing a useful reference for pre-IPO companies evaluating their own positions.

The Post-Listing Enforcement Risk Landscape

The SFC’s Market Misconduct Tribunal Powers

The Market Misconduct Tribunal (MMT), established under Part XIII of the SFO, has the power to impose sanctions for director misconduct related to conflict-of-interest disclosure failures. These sanctions include:

• Disqualification from being a director for up to 5 years
• Disgorgement of profits
• Fines of up to HKD 10 million
• Orders to pay the SFC’s investigation costs

The MMT’s jurisdiction extends to conduct that occurred before listing, provided the conduct is “relevant to the listing application or the company’s fitness for listing.” In a 2023 MMT decision (MMT-2023-05), the Tribunal disqualified a former director of a pre-IPO company for 3 years for failing to disclose a HKD 2.8 million personal loan from a substantial shareholder, even though the loan was repaid before the listing.

The Private Right of Action Under the SFO

Section 281 of the SFO provides a private right of action for investors who suffer loss as a result of a director’s failure to disclose a material conflict. This provision is increasingly being used in shareholder class actions in Hong Kong, particularly following the Court of Final Appeal’s 2024 decision in Chan v. ABC Ltd (FACV 12/2023), which confirmed that a director’s non-disclosure of a conflict in the prospectus constitutes a “misrepresentation” under the SFO. The damages available include the difference between the price paid for the shares and their actual value, plus interest.

For pre-IPO companies, this private right of action creates a direct financial exposure that extends beyond regulatory penalties. The average settlement value for shareholder class actions in Hong Kong involving pre-IPO disclosure failures was HKD 47 million in 2024, according to data from the Hong Kong Institute of Chartered Secretaries, with the costs typically borne by the company’s D&O insurance policy.

Actionable Takeaways for Pre-IPO Companies

1. Establish a formal conflict-of-interest register at least 18 months before the listing application, updated quarterly and audited annually, to provide a verifiable record for sponsor due diligence and regulatory review.

2. Require all directors and senior management to complete SFC-recognised training on Cap. 622 disclosure obligations and Listing Rules Chapter 14A connected transaction requirements at least 12 months before the listing application.

3. Conduct a full audit of all transactions with directors, senior management, and their associates for the 24-month period preceding the listing application, including indirect benefits such as personal guarantees and share pledges.

4. Adopt a board-approved conflict-of-interest policy that addresses declaration procedures, recusal mechanisms, and consequences of non-disclosure, with the policy disclosed in the prospectus.

5. Review all connected transactions against the de minimis thresholds in Listing Rules Rule 14A.76 and apply for waivers under Rule 14A.102 at least 6 months before the expected listing date to allow time for Exchange review.